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OBJECTIVES: Current U.S. Department of Health and Human Services (DHHS) 
HIV treatment guidelines recommend that HIV patients initiate first-line 
antiretroviral therapy (ART) with one of four “preferred” regimens: 
efavirenz/tenofovir/emtricitabine (EFV/TDF/FTC), ritonavir-boosted atazanavir + 
tenofovir/emtricitabine (ATV/r+TDF/FTC), ritonavir-boosted darunavir + 
tenofovir/emtricitabine (DRV/r+TDF/FTC), or raltegravir + tenofovir/emtricitabine 
(RAL+TDF/FTC). Adherence is critical to the success of ART in suppressing viral 
load and avoiding virological failure and development of drug resistance. This 
study compared ART adherence between preferred ART regimens in a real-world 
setting. METHODS: Retrospective study using U.S. Medicaid administrative 
health care claims from 15 states. Subjects were HIV patients aged 18-64 years 
who were enrolled in Medicaid and initiated, between January 1, 2007 and 
September 30, 2011, a first-line ART regimen “preferred” under U.S. DHHS HIV 
treatment guidelines published in March 2012. Patients were classified by ART 
regimen and were required to 4be continuously enrolled for 6 months before and 
≥3 months following ART initiation. Follow up lasted from ART initiation until a 
≥30 day gap in initiated ART, introduction of a new ART medication, or 
disenrollment. Adherence, defined as the proportion of days covered by ART 
medication during follow up (dichotomized at ≥80%), was evaluated using 
multivariable logistic regressions that adjusted for demographic and clinical 
factors. RESULTS: Sample included 1,979 patients initiating EFV/TDF/FTC 
(n=1,259), ATV/r+TDF/FTC (n=498), DRV/r+TDF/FTC (n=143), or RAL+TDF/FTC 
(n=79); mean age by regimen ranged from 40.1 to 42.1 years and proportion male 
from 44.1% to 55.4%. Compared with patients initiating EFV/TDF/FTC, odds of 
adherence ≥80% were significantly lower in DRV/r+TDF/FTC patients (odds ratio 
[OR]=0.56, p=0.045) and trended lower in RAL+TDF/FTC patients (OR=0.666, 
p=0.273) and ATV/r+TDF/FTC patients (OR=0.904, p=0.610). CONCLUSIONS: 
Among patients initiating a DHHS guideline-preferred first-line ART regimen, the 
odds of adherence were not the same for all regimens. Further research should 
explore the reasons for differences in adherence levels between “preferred” ART 
regimens.  
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OBJECTIVES: The study evaluated medication adherence and its association with 
CD4 cells response following interventions among patients receiving 
antiretroviral therapy (ART) in Specialist Hospital Sokoto, North Western Nigeria 
METHODS: This was cross-sectional study following adherence interventions 
that included training of health workers on cognitive and behavioural strategies 
for improving medication adherence; and a pre- and post-ART adherence 
counseling to patients. Out of 1300 patients on ART who were provided pre- and 
post-ART adherence counseling, announced pill counts were conducted in 365 
randomly selected patients. The CD4 cell count (cells/mm3) at months 0, 6, 12, 18 
and 24 were extracted from the patient’s records. One-way Anova was used to 
test the association between groups of variables and p<0.05 indicated statistical 
significance. RESULTS: Out of 365 participants sampled, data from 297 (81.4%) of 
them were valid for analysis. The mean age of participants was 34.7 (95%CI, 33.6–
35.8) years; 60.9% were females and 76.4% received an AZT/3TC/NVP regimen. 
The mean percent adherence was 83.4% (95%CI, 80.8–86.0); and 52.2% reported 
100% adherence level. With this mean adherence level, the mean CD4-cell count 
(cells/mm3) at ART initiation increased from 198.9 (95%CI, 180.7–217.1) to 396.5 
(95%CI, 368.3–24.7) at 6 months, 428.0 (95%CI, 400.4–455.6) at 12 months, 427.2 
(95%CI, 405.6–448.8) at 18 months, and 501.4 (95%CI, 469.5–533.3) at 24 months. 
This increase was statistically significant (p<0.05). The participants’ employment 
and educational status, age, sex and type of ART regimens received had no 
significant association with medication adherence (p>0.05). CONCLUSIONS: The 
study reported mean adherence level that is below the required >95% necessary 
to achieve the goals of ART. The increase in CD4 cells count over the observation 
period was statistically significant at the reported adherence level. Better 
immunologic outcomes may be achieved with higher adherence level.  
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OBJECTIVES: To determine if the SF-12 survey (using the PCS and MCS) can 
discriminate between predefined HIV severity states (as defined by CD4 and viral 
load) in a Kenyan population. The discriminative ability of the SF-12 quality of 
life instrument has been tested in patients with HIV/AIDS. In a US study, 
patients were stratified by CD4 count and viral load as a threshold for severity of 
disease. Associations between severity and mental component score 
(MCS)/physical component score (PCS) were investigated. The study found an 
association between CD4 threshold and PCS score. Using similar methods, we 
tested the same hypotheses using a Swahili translation of the SF-12 in a Kenyan 
population of HIV positive patients. METHODS: This cross-sectional study was 
based on data from a randomized controlled trial conducted in Nairobi, Kenya 
involving HIV patients. CD4 count, viral load, and SF-12 survey results were 
collected on patients initiating anti-retroviral therapy at 3 clinics. Clinical 
variables were stratified as follows: CD4≥200 cells/mm3compared to CD4<200 and 
viral load>55000 copies/mL compared to viral load ≤55000. The PCS and MCS 
scores means were compared across these strata using a t test. RESULTS: CD4 
counts were measured in 280 patients and viral load in 497 patients. All patients 
completed the SF-12 instrument. PCS scores showed significant discriminative 
ability in the CD4 comparison (p<0.01) with a mean(SD) of 41.3(11.42) for CD4<200 
cells/mm3compared to 45.1(11.2) for CD4≥200. Comparison in viral load strata 
and MCS scores were not significant. Mean and standard deviation for both MCS 
and PCS in each severity state were similar in value to those reported in the 
earlier American trial. CONCLUSIONS: These findings suggest that a Swahili 
translation of the SF-12 is a useful instrument in discriminating across limited 
clinical variables of HIV disease progression and severity.  
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OBJECTIVES: Physician’s perception regarding parents’ expectation to receive 
antibiotic prescription for their children is a significant predictor of 
overprescribing antibiotics for young children in the United States. The objective 
was to evaluate whether parents’ level of expectation would change after 
manipulating their ‘perceived benefits of using antibiotics’ and their ‘perceived 
barriers to visit doctors without any expectation of antibiotic prescription’. 
METHODS: A prospective experimental study was conducted using a structured 
data-collection instrument to manipulate perceived barriers and perceived 
benefits using four scenarios and keep other factors of Health Belief Model 
constant. Each subject viewed four scenarios; expectation associated with each 
scenario was measured using visual-analog-scale. Data were collected at public 
places (Houston,TX) from subjects who had at least one child (age≤5 years) 
during the study and who could speak, read and write English. Psychometric 
properties of the instrument were tested; descriptive and repeated measures 
mixed method covariance adjusted analyses were performed using SAS®9.3 with 
0.05 significance level. RESULTS: A total of 300 completed surveys were 
analyzed. Mean age of the sample was 30.3±7 years. The mean general 
expectation score (before reading any scenario) to receive antibiotic prescription 
for children was 53.6±25.7. The repeated measure mixed methods analyses 
indicated that there was 12-point reduction (p<0.0001) in expectation score after 
removing perceived barriers from the situational scenarios; 16-point decrease 
(p<0.0001) in expectation score was observed after removing perceived benefits 
and 18-point decrease (p<0.0001) in expectation score after removing both 
perceived barriers and perceived benefits. CONCLUSIONS: There was significant 
effect of perceived barriers and perceived benefits on expectation scores. When 
both perceived barriers and perceived benefits were removed from the scenarios 
there was the highest decrease in the expectation score indicating the successful 
manipulation of both variables. Policy makers and intervention programs should 
consider these factors to enhance successful reduction of antibiotic expectations.  
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OBJECTIVES: Vaccination rates for influenza and pneumococcal disease do not 
meet established goals in older minority populations. This project assessed 
potential reasons for this through a survey of community-dwelling African 
American seniors. METHODS: A 23-question survey was developed and fielded to 
a group of participants at a Philadelphia community senior center. Survey 
content was informed by previously-tested instruments in the literature and 
consisted of 18 Likert-scale items assessing potential barriers to pneumonia 
vaccine (PV) and influenza vaccine (IV); yes/no questions assessing awareness of 
PV and IV; and open-ended questions gathering opinions supporting and 
opposing these vaccines. RESULTS: A total of participants completed the survey. 
Awareness of PV was slightly lower than IV (36/39 vs. 39/39; p=.077) but there 
were no differences in perceived importance of PV versus IV. Most (91.9%) agreed 
that both vaccines are important to their health, but more than half (52.6%) felt 
that these vaccines can cause illness. Only a third (34.3%) believed that vaccines 
protect against pneumonia and influenza. Many participants (65.6%) indicated 
fear as a barrier to vaccination, with most of these (35.1%) specifying fear of 
illness or adverse reaction, 16.2% fear of needles, and 16.2% reporting other fears. 
While most trusted pharmacists as an information source for vaccination 
(75.7%), less than half (44.4%) are comfortable getting vaccines from pharmacists. 
CONCLUSIONS: This is the first survey to identify PV and IV barriers among 
African Americans through a community senior center. Though awareness of 
both vaccines is high, fear of vaccination is common and represents a significant 
barrier, as does the notion that these vaccines cause illness. Pharmacists are a 
trusted information source regarding vaccines but are not yet established as 
trusted vaccine providers in this population. Results serve to inform outcomes 
researchers’ efforts to design and evaluate vaccination programs targeted 
towards African American seniors.  
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